|
| SlNo |
Company Name & Country of Origin |
Indication |
Features |
|
|
| 1 |
AgeX Therapeutics 16
United States |
Regenerative Medicine |
Specializes in regenerative medicine using pluripotent stem cells. Focused on tissue engineering and cell-based therapies. |
|
| 2 |
Altos Labs 17
UK |
Cellular Rejuvenation |
Focuses on cellular rejuvenation programming to reverse age-related decline. High-profile team includes leading scientists and significant funding from Jeff Bezos. |
|
| 3 |
Amazentis (Timeline) 18
Switzerland |
Mitophagy & Muscle Health |
Pioneers in research on mitophagy and mitochondrial health. Offers Urolithin A-based products for improving muscle and cell performance. |
|
| 4 |
Apollo Health Ventures19
Germany |
Aging Research Investment |
Venture capital firm targeting companies with potential breakthroughs in aging. Supports translational research to bridge science and application. |
|
| 5 |
BioAge Labs 20
United States |
Aging Biomarker Discovery |
Leverages human aging data to identify biomarkers and drug targets to combat aging-related diseases. |
|
| 6 |
BioXtek21
United States |
Regenerative Technology |
Cutting-edge platform leverages the regenerative properties of amniotic membrane and other birth-derived tissues to address various age-related conditions. |
|
| 7 |
Calico Labs22
United States |
Aging-related Therapies |
Backed by Google’s Alphabet, focused on understanding the biology of aging. Develops therapies targeting age-related diseases through collaboration with AbbVie. |
|
| 8 |
Caristo Diagnostics23
Oxford, England |
Cardiovascular aging |
AI-based tool capable of predicting heart attacks up to a decade in advance by assessing coronary inflammation. This technology provides clinicians with a powerful tool to identify at-risk individuals and implement preventive measures. |
|
| 9 |
CHARACTER BIOSCIENCES 24
USA |
Disease Progression |
Integrates genomics, longitudinal clinical and imaging data, machine learning, and novel experimental approaches to identify the molecular drivers of disease progression and develop innovative targeted medicines. |
|
| 10 |
Chromadex (Tru Niagen) 25
United States |
NAD+ Mitochondrial Health |
Specializes in NAD+precursors to improve mitochondrial health. Products aimed at boosting energy and cellular repair. |
|
| 11 |
Deep Longevity26
Hong Kong |
AI for Biological Age |
Builds AI-driven models to measure biological age and predict longevity based on health and lifestyle factors. |
|
| 12 |
Dorian Therapeutics 27
USA |
Senescence Therapies |
They are developing senoblockers, a new class of therapeutics with a double function: blocking senescence while reactivating the regeneration capacity of a tissue. |
|
| 13 |
Elysium Health28
United States |
NAD+ Boosters & Aging |
Offers consumer-facing products like NAD+ boosters and health supplements. Develops and 12commercializes epigenetic biomarkers for aging. |
|
| 14 |
Glycan age29
UK |
Biological Age Testing |
Glycan Age is a simple, test that analyses glycobiology. Taking a GlycanAge® test is a vital step to determine once biological age. |
|
| 15 |
Gero30
Singapore |
Aging Biomarker Models |
Develops AI-driven solutions to study biomarkers of aging and resilience. Known for predictive models of healthspan. |
|
| 16 |
Insilico Medicine 31
Hong Kong |
Aging Research |
Combines AI with genomics to identify therapeutic targets for age-related diseases. Leader in using deep learning for drug discovery and aging research. |
|
| 17 |
Juvenescence 32
United Kingdom |
Aging-related Diseases |
A biotech company investing in and developing drugs to target aging and age-related conditions. Broad portfolio includes senolytics and metabolic regulators. |
|
| 18 |
Libella Gene Therapeutics 33
United States |
Telomere Lengthening |
Focused on telomere lengthening through gene therapy. Clinical trials for aging-related diseases are underway. |
|
| 19 |
Life Biosciences 34
United States |
Cellular Health Aging |
Aims to combat aging through research in epigenetics, mitochondrial health, and senescence. Focuses on restoring cellular health to extend lifespan. |
|
| 20 |
Longevity Vision Fund 35
United States |
Aging & Longevity Investment |
Focuses on funding startups in aging and longevity science. Invests in innovations targeting healthspan and lifespan extension. |
|
| 21 |
MICREGEN 36
UK |
Stem Cell Therapies |
Innovative approach in developing the Secretomix® platform to produce various secretome formulations from its first clinical grade master and working cell banks, could change how multiple critical and chronic problems are managed- not just the symptoms, but the root causes of diseases. They are primarily working on stem cells. |
|
| 22 |
ONE SKIN 37
USA |
Skin Aging Reversal |
Their products focus on skin longevity. One Skin’s proprietary peptide, OS-01, is an ingredient designed to reduce skin's biological age by improving skin barrier, supporting DNA damage repair, and preventing the accumulation of aged cells. |
|
| 23 |
Oisín Biotechnologies 38
USA |
Aging-related diseases |
Longevity therapeutics platform company focused on creating genetic medicines to combat a variety of age related diseases. Oisín Biotechnologies is developing a highly precise, DNA-targeted intervention to clear the senescent cells. As a recent study has shown, clearing senescent cells both reduces negative effects of aging pathologies and also extends median lifespan and survival. |
|
| 24 |
PULSE SIGHT 39
France |
Age-related Macular Degeneration |
Ophthalmology drug development company developing disruptive non-viral gene therapies with minimally invasive delivery technology to treat AMD. |
|
| 25 |
Rejuvenate Bio 40
United States |
Gene Therapy Aging |
Utilizes gene therapy to reverse age-related conditions in animals and humans. Targeting cardiovascular and metabolic diseases. |
|
| 26 |
SUZHOU Ruiming41
China |
Age-related Macular Degeneration |
The company has developed an eye-drop drug delivery technology for fundus diseases which include age-related wet macular degeneration (AMD), retinal vein occlusion, and diabetic macular edema. |
|
| 27 |
S-Biomedic 42
Belgium |
Skin Health Solutions |
Focused on skin health by pioneering the development of Pro- and Post-biotic ingredients from true skin commensals. |
|
| 28 |
SeaBeLife Biotech 43
France |
Neurodegenerative diseases |
Focuses on the development of molecules designed to block regulated necrosis – also known as regulated cell death. |
|
| 29 |
Sirona Biochem Corp 44
Canada |
Skin Health Solutions |
Developed a novel anti-aging compound designed to reverse the effects of aging on facial skin. |
|
| 30 |
Thorne HealthTech 45
United States |
Personalized Longevity |
Provides personalized health insights through testing kits. Focuses on nutritional solutions and longevity interventions. |
|
| 31 |
Turn Biotechnologies 46
United States |
Epigenetic Reprogramming |
Uses epigenetic reprogramming to restore youthful cell function. Targets applications in skin and muscle rejuvenation. |
|
| 32 |
Unity Biotechnology 47
United States |
Senolytic Therapies |
Focuses on eliminating senescent cells to address diseases like osteoarthritis, fibrosis, and neurodegenerative conditions. |
|
